{
    "1667818955912667136": {
        "author_id": "5383942",
        "created_at": "2023-06-11T09:00:00.000Z",
        "edit_history_tweet_ids": [
            "1667818955912667136"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 10,
                    "normalized_text": "EHA2023",
                    "probability": 0.7896,
                    "start": 4,
                    "type": "Other"
                },
                {
                    "end": 107,
                    "normalized_text": "BloodCancer",
                    "probability": 0.6558,
                    "start": 97,
                    "type": "Other"
                },
                {
                    "end": 220,
                    "normalized_text": "MultipleMyeloma",
                    "probability": 0.6317,
                    "start": 206,
                    "type": "Other"
                },
                {
                    "end": 239,
                    "normalized_text": "Myelofibrosis",
                    "probability": 0.7288,
                    "start": 227,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 11,
                    "start": 3,
                    "tag": "EHA2023"
                },
                {
                    "end": 108,
                    "start": 96,
                    "tag": "BloodCancer"
                },
                {
                    "end": 221,
                    "start": 205,
                    "tag": "MultipleMyeloma"
                },
                {
                    "end": 240,
                    "start": 226,
                    "tag": "Myelofibrosis"
                }
            ]
        },
        "id": "1667818955912667136",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 9152,
            "like_count": 12,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 1
        },
        "text": "As #EHA2023 ends, we are feeling inspired and invigorated after collaborating with the European #BloodCancer community this weekend. We look forward to using our learnings to advance treatment options for #MultipleMyeloma and #Myelofibrosis patients."
    }
}